{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T04:12:41Z","timestamp":1771906361165,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Card Electrophysiol Rev"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1023\/b:cepr.0000023143.98705.ee","type":"journal-article","created":{"date-parts":[[2004,4,8]],"date-time":"2004-04-08T01:10:56Z","timestamp":1081386656000},"page":"374-378","source":"Crossref","is-referenced-by-count":7,"title":["Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in"],"prefix":"10.1007","volume":"7","author":[{"given":"Carl","family":"van Walraven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Koudstaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"8","key":"5257229_CR1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22(8):983\u2013988.","journal-title":"Stroke"},{"issue":"8631","key":"5257229_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","volume":"1","author":"P Petersen","year":"1989","unstructured":"Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial ofwarfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989;1(8631):175\u2013179.","journal-title":"Lancet"},{"issue":"14","key":"5257229_CR3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","volume":"158","author":"AL Gullov","year":"1998","unstructured":"Gullov AL, KoefoedBG, Petersen P, Pedersen TS, Andersen ED, Godtfredsen J, Boysen G. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. Arch Intern Med 1998;158(14):1513\u20131521.","journal-title":"Arch Intern Med"},{"issue":"7215","key":"5257229_CR4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/bmj.319.7215.958","volume":"319","author":"BS Hellemons","year":"1999","unstructured":"Hellemons BS, Langenberg M, Lodder J, Vermeer F, Schouten H.J Lemmens T, van Ree J.W, Knottnerus J.A. Primary prevention of arterial thromboembolism in nonrheumatic atrial fibrillation in primary care: Randomised controlled trial comparing two intensities of coumarin with aspirin. Br Med J 1999;319(7215):958\u2013964.","journal-title":"Br Med J"},{"key":"5257229_CR5","doi-asserted-by":"crossref","unstructured":"Anonymous. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack orminor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342(8882):1255\u20131262.","DOI":"10.1016\/0140-6736(93)92358-Z"},{"key":"5257229_CR6","doi-asserted-by":"crossref","unstructured":"Anonymous. Stroke prevention in Atrial Fibrillation Study. Final results. Circulation 1991;84(2):527\u2013539.","DOI":"10.1161\/01.CIR.84.2.527"},{"key":"5257229_CR7","doi-asserted-by":"crossref","unstructured":"Anonymous. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke prevention in Atrial Fibrillation II study. Lancet 1994;343(8899):687\u2013691.","DOI":"10.1016\/S0140-6736(94)91577-6"},{"key":"5257229_CR8","doi-asserted-by":"crossref","unstructured":"Anonymous. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke prevention in Atrial Fibrillation III Study. The SPAF III writing committee for the stroke Prevention in Atrial Fibrillation Investigators. JAMA 1998;279(16):1273\u20131277.","DOI":"10.1001\/jama.279.16.1273"},{"key":"5257229_CR9","doi-asserted-by":"crossref","unstructured":"Anonymous. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348(9028):633\u2013638.","DOI":"10.1016\/S0140-6736(96)03487-3"},{"issue":"22","key":"5257229_CR10","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","volume":"323","author":"The effect of","year":"1990","unstructured":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. New England Journal of Medicine 1990;323(22):1505\u20131511.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"5257229_CR11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","volume":"18","author":"SJ Connolly","year":"1991","unstructured":"Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. Journal of the American College of Cardiology 1991;18(2):349\u2013355.","journal-title":"Journal of the American College of Cardiology"},{"issue":"20","key":"5257229_CR12","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","volume":"327","author":"MD Ezekowitz","year":"1992","unstructured":"Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. New England Journal of Medicine 1992;327(20):1406\u20131412.","journal-title":"New England Journal of Medicine"},{"key":"5257229_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","volume":"143","author":"H Diener","year":"1996","unstructured":"Diener H, Cunha L, Forbes C, et al. European stroke prevention study 2: Dipyridamole and acetylsalicylic acid in the prevention of stroke. Journal of Neurological Sciences 1996;143:1\u201313.","journal-title":"Journal of Neurological Sciences"},{"issue":"5","key":"5257229_CR14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.STR.28.5.1015","volume":"28","author":"C Morocutti","year":"1997","unstructured":"Morocutti C, Amabile G, Fattapposta F, Nicolosi A, Matteoli S, Trappolini M, Cataldo G, Milanesi G, Lavezzari M, Pamparana F, Coccheri S. Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. Stroke 1997;28(5):1015\u20131021.","journal-title":"Stroke"},{"issue":"1Pt1","key":"5257229_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-8703(99)70259-0","volume":"138","author":"IS Posada","year":"1999","unstructured":"Posada IS, Barriales V. Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group. American Heart Journal 1999;138(1 Pt 1):137\u2013143.","journal-title":"American Heart Journal"},{"issue":"4","key":"5257229_CR16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9149(98)00357-9","volume":"82","author":"V Pengo","year":"1998","unstructured":"Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F, Dalla Volta S. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. Am J Cardiol 1998;82(4):433\u2013437.","journal-title":"Am J Cardiol"},{"key":"5257229_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists","year":"2002","unstructured":"Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71\u201386.","journal-title":"Br Med J"},{"issue":"19","key":"5257229_CR18","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1001\/jama.281.19.1830","volume":"281","author":"MD Ezekowitz","year":"1999","unstructured":"Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA 1999;281(19):1830\u20131835.","journal-title":"JAMA"},{"issue":"9","key":"5257229_CR19","first-page":"811","volume":"13","author":"CJ Green","year":"1997","unstructured":"Green CJ, Hadorn DC, Bassett K, Kazanjian A. Anticoagulation in chronic nonvalvular atrial fibrillation: A critical appraisal and meta-analysis. Canadian Journal of Cardiology 1997;13(9):811\u2013815.","journal-title":"Canadian Journal of Cardiology"},{"issue":"3","key":"5257229_CR20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.STR.32.3.803","volume":"32","author":"RG Hart","year":"2001","unstructured":"Hart RG, Halperin JL. Atrial fibrillation and stroke: Concepts and controversies. Stroke 2001;32(3):803\u2013808.","journal-title":"Stroke"},{"issue":"10","key":"5257229_CR21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/106002809703101012","volume":"31","author":"PA Howard","year":"1997","unstructured":"Howard PA, Duncan PW. Primary stroke prevention in nonvalvular atrial fibrillation: Implementing the clinical trial findings. Annals of Pharmacotherapy 1997;31(10):1187\u20131196.","journal-title":"Annals of Pharmacotherapy"},{"key":"5257229_CR22","unstructured":"Koudstaal PJ. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2000; (2):CD000187."},{"key":"5257229_CR23","unstructured":"Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2000; (2):CD000185."},{"issue":"5","key":"5257229_CR24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/1047-2797(93)90117-M","volume":"3","author":"DE. Singer","year":"1993","unstructured":"Singer DE. Overview of the randomized trials to prevent stroke in atrial fibrillation. Annals of Epidemiology 1993;3(5):563\u2013567.","journal-title":"Annals of Epidemiology"},{"issue":"7282","key":"5257229_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bmj.322.7282.321","volume":"322","author":"FC Taylor","year":"2001","unstructured":"Taylor FC, Cohen H, Ebrahim S. Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. Br Med J 2001;322(7282):321\u2013326.","journal-title":"Br Med J"},{"key":"5257229_CR26","first-page":"CD001938","volume":"1","author":"JB Segal","year":"2001","unstructured":"Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Cochrane Database Systematic Reviews 2001;1:CD001938.","journal-title":"Cochrane Database Systematic Reviews"},{"issue":"9","key":"5257229_CR27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7326\/0003-4819-115-9-727","volume":"115","author":"GW Albers","year":"1991","unstructured":"Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Stroke prevention in nonvalvular atrial fibrillation. Annals of Internal Medicine 1991;115(9):727\u2013736.","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"5257229_CR28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ana.410300402","volume":"30","author":"GW Albers","year":"1991","unstructured":"Albers GW, Sherman DG, Gress DR, Paulseth JE, Petersen P. Stroke prevention in nonvalvular atrial fibrillation: Areview of prospective randomized trials. Ann Neurol 1991;30(4):511\u2013518.","journal-title":"Ann Neurol"},{"issue":"13","key":"5257229_CR29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archinte.1994.00420130030006","volume":"154","author":"GW. Albers","year":"1994","unstructured":"Albers GW. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med 1994;154(13):1443\u20131448.","journal-title":"Arch Intern Med"},{"issue":"14","key":"5257229_CR30","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archinte.158.14.1487","volume":"158","author":"GW. Albers","year":"1998","unstructured":"Albers GW. Choice of antithrombotic therapy for stroke prevention in atrial fibrillation: Warfarin, aspirin, or both? Arch Intern Med 1998;158(14):1487\u20131491.","journal-title":"Arch Intern Med"},{"issue":"2Suppl","key":"5257229_CR31","doi-asserted-by":"crossref","first-page":"118S","DOI":"10.1378\/chest.95.2_Supplement.118S","volume":"95","author":"M Dunn","year":"1989","unstructured":"Dunn M, Alexander J, de Silva R, Hildner F. Antithrombotic therapy in atrial fibrillation. Chest 1989;95(2 Suppl):118S\u2013127S.","journal-title":"Chest"},{"issue":"4","key":"5257229_CR32","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0735-1097(01)01587-X","volume":"38","author":"V Fuster","year":"2001","unstructured":"Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, PrystowskyEN, Wann LS, WyseDG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A, American College of Cardiology\/American Heart Association\/European Society of Cardiology Board ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Journal of the American College of Cardiology 2001;38(4):1231\u20131266.","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"5257229_CR33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-134-6-200103200-00011","volume":"134","author":"BF Gage","year":"2001","unstructured":"Gage BF, Fihn SD, White RH. Warfarin therapy for an octogenarian who has atrial fibrillation. Annals of Internal Medicine 2001;134(6):465\u2013474.","journal-title":"Annals of Internal Medicine"},{"issue":"17","key":"5257229_CR34","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/archinte.1994.00420170093009","volume":"154","author":"LK Gottlieb","year":"1994","unstructured":"Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 1994;154(17):1945\u20131953.","journal-title":"Arch Intern Med"},{"issue":"3","key":"5257229_CR35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.51.3.674","volume":"51","author":"RG Hart","year":"1998","unstructured":"Hart RG, Sherman DG, Easton JD, Cairns JA. Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 1998;51(3):674\u2013681.","journal-title":"Neurology"},{"issue":"2","key":"5257229_CR36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02599816","volume":"1","author":"JM Kitchens","year":"1986","unstructured":"Kitchens JM, Flegel KM. Atrial fibrillation, stroke and anticoagulation: What is to be done?. J Gen Intern Med 1986;1(2):126\u2013129.","journal-title":"J Gen Intern Med"},{"issue":"7","key":"5257229_CR37","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Annals of Internal Medicine 1999;131(7):492\u2013501.","journal-title":"Annals of Internal Medicine"},{"issue":"1Suppl","key":"5257229_CR38","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1378\/chest.119.1_suppl.194S","volume":"119","author":"GW Albers","year":"2001","unstructured":"Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001;119(1 Suppl):194S\u2013206S.","journal-title":"Chest"},{"key":"5257229_CR39","doi-asserted-by":"crossref","unstructured":"Anonymous. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med 1996;156(4):409\u2013416.","DOI":"10.1001\/archinte.1996.00440040081009"},{"issue":"2","key":"5257229_CR40","doi-asserted-by":"crossref","first-page":"A17","DOI":"10.7326\/ACPJC-2001-135-2-A17a","volume":"135","author":"S Ebrahim","year":"2001","unstructured":"Ebrahim S, Taylor F. Review: Anticoagulantsmay be better than antiplatelet agents for nonfatal stroke but not other vascular or fatal events in nonrheumatic AF. ACP Journal Club 2001;135(2):A17.","journal-title":"ACP Journal Club"},{"issue":"1","key":"5257229_CR41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0895-4356(02)00507-3","volume":"56","author":"M Rahman","year":"2003","unstructured":"Rahman M, Sakamoto, Fukui T. Conditional versus unconditional logistic regression in the medical literature. J Clin Epidemiol 2003;56(1):101\u2013102.","journal-title":"J Clin Epidemiol"},{"key":"5257229_CR42","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","volume":"288","author":"C van Walraven","year":"2002","unstructured":"van Walraven C, Hart RG., Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation. An individual patient meta-analysis. JAMA 2002;288:2441\u20132448.","journal-title":"JAMA"},{"issue":"13","key":"5257229_CR43","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","author":"Atrial Fibrillation Investigators.","year":"1994","unstructured":"Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154(13):1449\u20131457.","journal-title":"Arch Intern Med"}],"container-title":["Cardiac Electrophysiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CEPR.0000023143.98705.ee.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:CEPR.0000023143.98705.ee\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CEPR.0000023143.98705.ee.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:36:47Z","timestamp":1751823407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:CEPR.0000023143.98705.ee"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["5257229"],"URL":"https:\/\/doi.org\/10.1023\/b:cepr.0000023143.98705.ee","relation":{},"ISSN":["1385-2264","1573-725X"],"issn-type":[{"value":"1385-2264","type":"print"},{"value":"1573-725X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}